Clinical trial
The Effect of β2 Genetic Polymorphisms on the Brochodilatation Effect of Albuterol ex-Vivo
NCT00162422 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of β2 Genetic Polymorphisms on the Brochodilatation Effect of Albuterol ex-Vivo
- Lead sponsor
- Hadassah Medical Organization
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2003
- Completion date
- Not reported
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.